Rx ingredients found in U.K. herbal
This article was originally published in The Tan Sheet
The Medicines and Healthcare products Regulatory Agency seizes a traditional Chinese medicinal product sold in the U.K., Jia Yi Jian, after the product tested positive for high levels of prescription-only ingredients. The agency said April 7 that the adulterated product "presents a clear risk to consumers" by using natural ingredient claims to distract from what are likely "very low manufacturing and ethical standards." Lab testing showed Jia Yi Jian, manufactured by Hu Nan Aimin Pharmaceuticals, contains more than twice the legal dosage of the erectile dysfunction drug tadalafil, the active ingredient in Lilly's prescription Cialis, and more than four times the legal dosage of the obesity drug sibutramine, the active ingredient in Abbott's prescription Meridia
You may also be interested in...
EU Regulatory Roundup, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.